Pharvaris reports Q4 results

• Pharvaris press release (NASDAQ:PHVS): Q4 GAAP EPS of -€0.74
• Cash and cash equivalents were approximately €391 million as of December 31, 2023, compared to approximately €162 million for December 31, 2022.

More on Pharvaris

• Pharvaris: Digging Deep For Sufficient Market Size
• Pharvaris rises as FDA lifts hold on hereditary angioedema candidate
• Seeking Alpha’s Quant Rating on Pharvaris
• Historical earnings data for Pharvaris
• Financial information for Pharvaris